BiomX Analyst Ratings
BiomX Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/14/2023 | 1742.11% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 08/09/2023 | 1742.11% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 05/15/2023 | 1742.11% | HC Wainwright & Co. | $10 → $7 | Maintains | Buy |
| 11/10/2022 | 426.32% | Chardan Capital | $6 → $2 | Maintains | Buy |
| 05/24/2022 | 1478.95% | Chardan Capital | $10 → $6 | Maintains | Buy |
| 05/12/2022 | 2005.26% | Ladenburg Thalmann | $13 → $8 | Maintains | Buy |
| 11/16/2021 | 3321.05% | Chardan Capital | $16 → $13 | Maintains | Buy |
| 10/19/2021 | 4110.53% | Chardan Capital | $28 → $16 | Maintains | Buy |
| 10/18/2021 | 2531.58% | HC Wainwright & Co. | $20 → $10 | Maintains | Buy |
| 04/15/2021 | 6478.95% | Ladenburg Thalmann | → $25 | Initiates Coverage On | → Buy |
| 12/07/2020 | 5163.16% | HC Wainwright & Co. | → $20 | Initiates Coverage On | → Buy |
| 01/09/2020 | 4110.53% | Cantor Fitzgerald | → $16 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析師事務所 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/14/2023 | 1742.11% | HC Wainwright & Co. | → 7 美元 | 重申 | 購買 → 購買 |
| 08/09/2023 | 1742.11% | HC Wainwright & Co. | → 7 美元 | 重申 | → 購買 |
| 05/15/2023 | 1742.11% | HC Wainwright & Co. | 10 美元 → 7 美元 | 維護 | 購買 |
| 2022 年 10 月 11 日 | 426.32% | 查丹資本 | 6 美元 → 2 美元 | 維護 | 購買 |
| 2022 年 5 月 24 日 | 1478.95% | 查丹資本 | 10 美元 → 6 美元 | 維護 | 購買 |
| 05/12/2022 | 2005.26% | 拉登堡塔爾曼 | 13 美元 → 8 美元 | 維護 | 購買 |
| 11/16/2021 | 3321.05% | 查丹資本 | 16 美元 → 13 美元 | 維護 | 購買 |
| 10/19/2021 | 4110.53% | 查丹資本 | 28 美元 → 16 美元 | 維護 | 購買 |
| 2021 年 10 月 18 日 | 2531.58% | HC Wainwright & Co. | 20 美元 → 10 美元 | 維護 | 購買 |
| 04/15/2021 | 6478.95% | 拉登堡塔爾曼 | → 25 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 12/07/2020 | 5163.16% | HC Wainwright & Co. | → 20 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 2020 年 9 月 1 日 | 4110.53% | 坎託·菲茨傑拉德 | → 16 美元 | 啓動覆蓋範圍開啓 | → 超重 |
What is the target price for BiomX (PHGE)?
BiomX（PHGE）的目標價格是多少？
The latest price target for BiomX (AMEX: PHGE) was reported by HC Wainwright & Co. on November 14, 2023. The analyst firm set a price target for $7.00 expecting PHGE to rise to within 12 months (a possible 1742.11% upside). 3 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年11月14日公佈了BiomX（美國證券交易所股票代碼：PHGE）的最新目標股價。該分析公司將目標股價設定爲7.00美元，預計PHGE將在12個月內上漲至7.00美元（可能上漲1742.11％）。去年有3家分析公司公佈了評級。
What is the most recent analyst rating for BiomX (PHGE)?
BiomX（PHGE）的最新分析師評級是多少？
The latest analyst rating for BiomX (AMEX: PHGE) was provided by HC Wainwright & Co., and BiomX reiterated their buy rating.
BiomX（美國證券交易所股票代碼：PHGE）的最新分析師評級由HC Wainwright & Co. 提供，BioMx重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for BiomX (PHGE)?
BiomX（PHGE）的下一個分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BiomX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BiomX was filed on November 14, 2023 so you should expect the next rating to be made available sometime around November 14, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與BiomX的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應獲得4個評級。BiomX的最後一次評級是在2023年11月14日提交的，因此您應該預計下一個評級將在2024年11月14日左右公佈。
Is the Analyst Rating BiomX (PHGE) correct?
分析師評級 BiomX (PHGE) 是否正確？
While ratings are subjective and will change, the latest BiomX (PHGE) rating was a reiterated with a price target of $0.00 to $7.00. The current price BiomX (PHGE) is trading at is $0.38, which is within the analyst's predicted range.
儘管評級是主觀的，並將發生變化，但最新的BiomX（PHGE）評級被重申，目標股價爲0.00美元至7.00美元。BiomX（PHGE）當前的交易價格爲0.38美元，在分析師的預測範圍內。